Increased levels of nitric oxide metabolites in urine from leprosy patients in reversal reaction

Leprosy Review

Volumn 70, Issue 1, 1999, Pages 52-55

  Schön, Thomas ^c   Gebre, Negussie ^a   Sundqvist, Tommy ^c   Selassie HMariam, Haile ^b   Engeda, Taye ^b   Britton, Sven ^a  

^a ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^b All Africa Leprosy Rehabilitation and Training   (Ethiopia)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

NITRATE; NITRIC OXIDE; NITRITE; STEROID;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHIOPIA; FEMALE; HUMAN; LEPROSY; MALE; METABOLITE; REVERSAL REACTION; URINE LEVEL;

EID: 0032899502     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: 10.5935/0305-7518.19990011     Document Type: Article

References (18)

1. Editorial. Lepr Rev, 1997; 68: 195-200.
2. Gelber HG. Leprosy (Hansen's disease). In: Mandell GL, Bennet JE, Dolin R. Mandell, eds. Douglas and Bennett's principles and practice of infectious diseases. Churchill Livingstone, New York, 1995; 2243-2250.
3. Ridley DS, Jopline WH. Classification of leprosy according to immunity. A five group system. Int J Lepr, 1966; 34: 255-273.
4. Änggård E. Nitric oxide: mediator, murderer and medicine. Lancet, 1994; 343: 1199-1206.
5. Chan J, Xing Y, Magliozzo RS, Bloom BR. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J Exp Med, 1992; 175: 1111-1122.
6. Chan J, Tanaka K, Carrol D, Flynn J, Bloom BR. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect Immun, 1995; 63: 736-740.
7. Nicholson S, Bonecini-Almeida M, Lapa e Silva JR, Nathan C, Xie Qiao-wen, Mumford R, Weidner JR, Calaycay J, Geng J, Boechat N, Linhares C, Rom W, Ho JL. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med, 1996; 183: 2293-2302.
8. Adams LB, Franzblau SG, Vavrin Z, Hibbs Jr JB, Krahenbuhl JL. L-Arginine-dependent macrophage effector functions inhibit metabolic activity of Mycobacterium laprae. J Immunol, 1991; 147: 1642-1646.
9. Khare S, Bhutani LK, Rao DN. Release of reactive nitrogen intermediates from the peripheral blood-derived monocytes/macrophages of leprosy patients stimulated in vitro by tuftsin. Lepr Rev, 1997: 68: 16-24.
10. Khanolkar-Young S, Snowdown D, Lockwood DNJ. Immunocytochemical localisation of inducible nitric oxide synthase and transforming growth factor-β in leprosy lesions. Clin Exp Immunol, 1998; 113: 438-442.
11. Giliam MB, Sherman MP, Griscavage JM, Ignarro LJ. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase. Anal Biochem, 1993; 212: 259-265.
12. MacMicking J, Xie Qiao-Wen, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol, 1997; 15: 323-350.
13. DeGroote MA, Fang FC. NO inhibitions: antimicrobial properties of nitric oxide. Clin Invest Dis, 1995; 21: S162-165.
14. Hibbs Jr JB, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, Ward JH, Menlove RL, McMurry MP, Kushner JP, Samlowski WE. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest, 1992; 89: 867-877.
15. Anstey NM, Weinberg JB, Hassanali MY, Mwaikambo ED, Manyenga D, Misukonis MA, Arnelle DR, Hollis D, McDonald MI, Granger DL. Nitric oxide in Tanzanian children with malaria: inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression. J Exp Med, 1996; 184: 557-567.
16. Sundqvist T, Laurin P, Fälth-Magnusson K, Magnusson K-E, Stenhammar L. Significantly increased levels of nitric oxide products in urine of children with celiac disease. J Pediat Gastroenterol Nutr, 1998; 27: 196-198.
17. Green LC, De Luzuriaga KR, Wagner DA, Rand W, Istfan N, Young VR, Tannenbaum SR. Nitrate biosynthesis in man. Proc Natl Acad Sci USA, 1981; 84: 6369-6373.
18. Oudkerk Pool M, Bouma G, Visser JJ, Kolkman JJ, Tran DD, Meuwissen SGM, Pena AS. Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand J Gastroenterol, 1995; 30: 784-788.